AP NEWS
Press release content from Business Wire. The AP news staff was not involved in its creation.
PRESS RELEASE: Paid content from Business Wire
Press release content from Business Wire. The AP news staff was not involved in its creation.

Incyte to Present at Upcoming Investor Conferences

May 2, 2019

WILMINGTON, Del.--(BUSINESS WIRE)--May 2, 2019--Incyte Corporation (Nasdaq:INCY) announced today that it will present at the following investor conferences during the month of May:

  • Bank of America Merrill Lynch Health Care Conference on Tuesday, May 14, 2019 at 8:40 am (PDT) in Las Vegas;
  • UBS Global Healthcare Conference on Monday, May 20, 2019 at 3:00 pm (EDT) in New York; and
  • RBC Capital Markets Healthcare Conference on Tuesday, May 21, 2019 at 10:30 am (EDT) in New York

The presentations will be webcast live and can be accessed at www.incyte.com in the Investors section under “Events and Presentations.” Investors interested in listening to the live webcast should log on before the start time in order to download any software required.

About Incyte

Incyte Corporation is a Wilmington, Delaware-based biopharmaceutical company focused on the discovery, development and commercialization of proprietary therapeutics. For additional information on Incyte, please visit the Company’s web site at www.incyte.com.

Follow @Incyte on Twitter at https://twitter.com/Incyte.

View source version on businesswire.com:https://www.businesswire.com/news/home/20190502005003/en/

CONTACT: Media

Catalina Loveman

+1 302 498 6171

cloveman@incyte.comInvestors

Michael Booth, DPhil

+1 302 498 5914

mbooth@incyte.com

KEYWORD: UNITED STATES NORTH AMERICA DELAWARE

INDUSTRY KEYWORD: HEALTH BIOTECHNOLOGY ONCOLOGY PHARMACEUTICAL RESEARCH SCIENCE

SOURCE: Incyte Corporation

Copyright Business Wire 2019.

PUB: 05/02/2019 08:00 AM/DISC: 05/02/2019 08:01 AM

http://www.businesswire.com/news/home/20190502005003/en